Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001315863-25-000873·Affinity Asset Advisors, LLC
Schedule 13G ownership disclosure
Forte Biosciences Inc
Common Stock, par value $0.001 per share · CUSIP: 34962G208
Event date: 2025-12-17
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Affinity Asset Advisors, LLC
Shares: 862,400 · Class: 6.9%
- Affinity Healthcare Fund, LP
Shares: 862,400 · Class: 6.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001315863-25-000873
- Form type
- SCHEDULE 13G
- Filer
- Affinity Asset Advisors, LLC
- CIK
- CIK 1773195
- Filed
- Dec 23, 2025
- Reporting period
- Dec 17, 2025
- Description
- Schedule 13G beneficial ownership